[Skip to Content]
[Skip to Content Landing]
April 1984

Ototoxic Effect of Erythromycin Therapy

Arch Otolaryngol. 1984;110(4):258-260. doi:10.1001/archotol.1984.00800300050011

• Thirty-two cases of sudden, symmetrical, high-frequency, sensorineural hearing loss associated with intravenous (IV) and oral erythromycin therapy have been published since 1973. We treated a patient with reversible ototoxicity associated with IV erythromycin for the treatment of legionnaire's disease.

(Arch Otolaryngol 1984;110:258-260)